Literature DB >> 26027531

Combinations with checkpoint inhibitors at wavefront of cancer immunotherapy.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26027531     DOI： 10.1038/nrd4648

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

1.  Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Authors:  Smruthy Sivakumar; F Anthony San Lucas; Tina L McDowell; Wenhua Lang; Li Xu; Junya Fujimoto; Jianjun Zhang; P Andrew Futreal; Junya Fukuoka; Yasushi Yatabe; Steven M Dubinett; Avrum E Spira; Jerry Fowler; Ernest T Hawk; Ignacio I Wistuba; Paul Scheet; Humam Kadara
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

2.  High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma.

Authors:  Yongyun Luo; Yaqin He; Xiaoping Ye; Jianjun Song; Qi Wang; Yukui Li; Xiaoliang Xie
Journal:  Pathol Oncol Res       Date:  2019-01-06       Impact factor: 3.201

3.  Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.

Authors:  Carmela Passaro; Quazim Alayo; Isabella De Laura; John McNulty; Korneel Grauwet; Hirotaka Ito; Vivek Bhaskaran; Marco Mineo; Sean E Lawler; Khalid Shah; Maria C Speranza; William Goins; Eric McLaughlin; Soledad Fernandez; David A Reardon; Gordon J Freeman; E Antonio Chiocca; Hiroshi Nakashima
Journal:  Clin Cancer Res       Date:  2018-10-02       Impact factor: 12.531

Review 4.  Cancer immunotherapy: the beginning of the end of cancer?

Authors:  Sofia Farkona; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  BMC Med       Date:  2016-05-05       Impact factor: 8.775

5.  Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis.

Authors:  Marco A J Iafolla; Cindy Yang; Vinod Chandran; Melania Pintilie; Quan Li; Philippe L Bedard; Aaron Hansen; Stephanie Lheureux; Anna Spreafico; Albiruni A Razak; Sevan Hakgor; Amanda Giesler; Trevor J Pugh; Lillian L Siu
Journal:  JNCI Cancer Spectr       Date:  2020-12-29

6.  Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry.

Authors:  Milena Music; Marco Iafolla; Antoninus Soosaipillai; Ihor Batruch; Ioannis Prassas; Melania Pintilie; Aaron R Hansen; Philippe L Bedard; Stephanie Lheureux; Anna Spreafico; Albiruni Abdul Razak; Lillian L Siu; Eleftherios P Diamandis
Journal:  F1000Res       Date:  2020-05-07

7.  Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.

Authors:  Neil L Berinstein; Michael McNamara; Ariane Nguyen; James Egan; Gregory T Wolf
Journal:  Oncoimmunology       Date:  2018-02-21       Impact factor: 8.110

8.  High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation.

Authors:  Chao-Qin Shen; Ting-Ting Yan; Wei Liu; Xiao-Qiang Zhu; Xiang-Long Tian; Xue-Liang Fu; Rong Hua; Jun-Feng Zhang; Yan-Miao Huo; De-Jun Liu; Jian-Yu Yang; Yong-Wei Sun; Jing-Yuan Fang; Hao-Yan Chen; Jie Hong
Journal:  J Cancer       Date:  2017-09-12       Impact factor: 4.207

9.  Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.

Authors:  Melanie Rinas; Jakob Wirbel; Marti Bernardo-Faura; Inna Pertsovskaya; Vicky Pliaka; Dimitris E Messinis; Gemma Vila; Theodore Sakellaropoulos; Wolfgang Faigle; Pernilla Stridh; Janina R Behrens; Tomas Olsson; Roland Martin; Friedemann Paul; Leonidas G Alexopoulos; Pablo Villoslada; Julio Saez-Rodriguez
Journal:  Genome Med       Date:  2021-07-16       Impact factor: 11.117
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.